Healwell AI

Telemedicine And EHR Adoption Will Revolutionize Healthcare AI

AnalystHighTarget

Not Invested

Consensus Narrative from 11 Analysts

Published

10 Aug 25

AnalystHighTarget's Fair Value

CA$5.00

74.2% undervalued

10 Sep

CA$1.29

-11.6%

-3.0%

-11.6%

-3.0%

You can edit this narrative until Aug 10 10:20 PM. Then, changes will post as Updates.

Author's Valuation

CA$5.0

74.2% undervalued

AnalystHighTarget Fair Value

Narrative

Updates0

AnalystHighTarget Fair Value

CA$5

74.2% undervalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

26.11%

Healthcare Services revenue growth rate

0.24%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

5.97%

Calculation

CA$26.34m

Earnings '28

131.86x

PE Ratio '28

CA$3.47b

Market Cap '28

CA$3.47b

Market Cap '28

583.83m

No. shares '28

CA$5.95

Share Price '28

CA$5.95 Share Price '28

Discounted to 2025 @ 5.97% p.a.

CA$5.00

Fair Value '25